Advertisement
Mr. Pope, 43, was most recently the Worldwide President of Cordis, amultibillion dollar franchise within Johnson and Johnson's medical devicesector.
Advertisement
"TransEnterix has made rapid and substantial progress since securing itsfirst institutional financing this past December," said Fred McCoy, Chairmanof the Board. "Now preparing to enter the extensive minimally-invasivesurgery market, which is expected to be an $8 billion global market in 2008,it is essential to have seasoned and successful CEO leadership. Todd Pope isjust such a leader."
Mr. Pope spent a total of 10 years at various leadership positions atJohnson and Johnson and Boston Scientific before joining TransEnterix.
"It has been my good fortune to have participated in two of the mostsignificant growth revolutions in medical devices with laparoscopic surgery inthe 1990s and drug-eluting stents in the early 2000s," Mr. Pope said. "Webelieve our company is poised to experience tremendous growth for years tocome and I am excited to have the opportunity to lead TransEnterix from itsearliest stages."
Mr. Pope is a Raleigh native and a graduate of the University of NorthCarolina at Chapel Hill. He and his family currently reside in Chapel Hill,NC.
About TransEnterix
TransEnterix, Inc. was founded in 2006 and in December, 2007, secured $21million in its first round of institutional financing. The company is rapidlydeveloping single port and NOTES (Natural Orifice Translumenal EndoscopicSurgery) product platforms for procedures that currently use traditionallaparoscopic approaches.Contact: Len Hall Allen & Caron Inc [email protected] 949.474.4300
SOURCE TransEnterix, Inc.
